Techcyte Announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability
Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the completion of a $15 million capital raise led by Van Tuyl Companies, with participation from existing investors Zoetis Inc. (“Zoetis”) and Mayo Clinic.
Techcyte Unveils Fusion, the First Unified Anatomic and Clinical Digital Pathology Platform
Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows. By bringing together pathology teams, IT systems, and AI into a single, integrated platform, Fusion aims to eliminate workflow silos, enhance diagnostic accuracy, and improve interoperability, setting a new industry standard for digital pathology.
Mayo Clinic Platform and Techcyte Announce a Strategic Collaboration to Transform the Global Practice of Pathology
Mayo Clinic Platform, which enables global healthcare transformation through new technologies and a new approach to innovation, and Techcyte, a world leader in AI-based digital pathology, are working together to transform the global practice of pathology through the creation of a digital pathology platform.
Techcyte Announces a Strategic Collaboration with Mayo Clinic to Create New Diagnostic Tests
Techcyte announced today a strategic collaboration with Mayo Clinic to create new AI algorithms and workflows on the Techcyte Clinical Pathology AI Platform.
